AUTHOR=Hamami Feline , Gerkensmeier Skadi , Münchau Alexander , Weissbach Anne TITLE=ε-sarcoglycan myoclonus-dystonia—overview of neurophysiological, behavioral, and imaging characteristics JOURNAL=Dystonia VOLUME=3 YEAR=2024 URL=https://www.frontierspartnerships.org/journals/dystonia/articles/10.3389/dyst.2024.11693 DOI=10.3389/dyst.2024.11693 ISSN=2813-2106 ABSTRACT=

Myoclonus-Dystonia is a rare, neurological movement disorder, clinically characterized by myoclonic jerks and dystonic symptoms, such as cervical dystonia and writer’s cramp. Psychiatric symptoms, like anxiety, depression, and addiction, are frequently reported. Monogenic Myoclonus-Dystonia is mostly caused by pathogenic variants in the ε-sarcoglycan gene, which is among other regions highly expressed in the cerebellum. The current pharmacological treatment is not satisfactory. Neurophysiological and imaging studies in this patient population are scarce with partly heterogeneous results and sometimes important limitations. However, some studies point towards subcortical alterations, e.g., of the cerebellum and its connections. Further studies addressing previous limitations are important for a better understanding of the underlying pathology of Myoclonus-Dystonia and might build a bridge for the development of future treatment.